Neoadjuvant chemoradiotherapy followed by surgery is associated with better survival outcomes in patients with locally advanced esophageal squamous cell carcinoma.
作者信息
Yoshida Naoya, Baba Hideo
机构信息
Division of translational research and advanced treatment against gastrointestinal cancer, Kumamoto University, Kumamoto, Japan.
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
出版信息
J Thorac Dis. 2018 Sep;10(Suppl 26):S3067-S3068. doi: 10.21037/jtd.2018.08.78.
Abstract
摘要
相似文献
1
Neoadjuvant chemoradiotherapy followed by surgery is associated with better survival outcomes in patients with locally advanced esophageal squamous cell carcinoma.
J Thorac Dis. 2018 Sep;10(Suppl 26):S3067-S3068. doi: 10.21037/jtd.2018.08.78.
2
CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cTNM) (NCT03001596).
BMC Cancer. 2017 Jun 28;17(1):450. doi: 10.1186/s12885-017-3446-7.
3
The impact of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced squamous cell carcinoma of esophagus.
J Chin Med Assoc. 2018 Jan;81(1):18-24. doi: 10.1016/j.jcma.2017.08.007. Epub 2017 Oct 20.
4
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
World J Surg Oncol. 2018 Jul 14;16(1):141. doi: 10.1186/s12957-018-1444-0.
5
[Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].
Chirurg. 2020 May;91(5):379-383. doi: 10.1007/s00104-020-01150-6.
6
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2710-2721.e3. doi: 10.1016/j.jtcvs.2018.01.086. Epub 2018 Feb 15.
7
Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial.
Radiother Oncol. 2019 Dec;141:27-32. doi: 10.1016/j.radonc.2019.07.031. Epub 2019 Aug 17.
8
Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case-control study.
Radiother Oncol. 2015 Aug;116(2):262-8. doi: 10.1016/j.radonc.2015.07.020. Epub 2015 Aug 1.
9
A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer.
Cancer Chemother Pharmacol. 2019 Nov;84(5):1115-1123. doi: 10.1007/s00280-019-03944-w. Epub 2019 Sep 9.
10
Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.
Dis Esophagus. 2014 May-Jun;27(4):355-9. doi: 10.1111/dote.12126. Epub 2013 Aug 29.
引用本文的文献
1
Metachronous Squamous Cell Carcinoma of the Esophagus After Resolution of Previous Adenocarcinoma.
ACG Case Rep J. 2023 Jul 8;10(7):e01097. doi: 10.14309/crj.0000000000001097. eCollection 2023 Jul.
2
Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010).
Ann Transl Med. 2021 Oct;9(20):1516. doi: 10.21037/atm-21-3331.
本文引用的文献
1
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
World J Surg Oncol. 2018 Jul 14;16(1):141. doi: 10.1186/s12957-018-1444-0.
2
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
Lancet. 2018 Jun 23;391(10139):2537-2545. doi: 10.1016/S0140-6736(18)31078-X.
3
Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy.
Surgery. 2018 Mar 5. doi: 10.1016/j.surg.2018.01.011.
4
Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
Cancer. 2017 Oct 15;123(20):3904-3915. doi: 10.1002/cncr.30823. Epub 2017 Jun 13.
5
TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma.
J Cancer. 2017 Feb 25;8(4):683-690. doi: 10.7150/jca.17048. eCollection 2017.
6
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society.
Esophagus. 2015;12(1):1-30. doi: 10.1007/s10388-014-0465-1. Epub 2014 Nov 11.
7
Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer.
Cancer Chemother Pharmacol. 2015 Mar;75(3):449-55. doi: 10.1007/s00280-014-2659-6. Epub 2014 Dec 28.
8
Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):872-9. doi: 10.1016/j.ijrobp.2014.03.030. Epub 2014 May 24.
9
Preoperative chemoradiotherapy for esophageal or junctional cancer.
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
10
Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):684-90. doi: 10.1016/j.ijrobp.2010.06.033. Epub 2010 Oct 6.
Zotero 插件